{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T21:27:30Z","timestamp":1781904450869,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","advancesradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.adro.2024.101696","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T18:08:23Z","timestamp":1733249303000},"page":"101696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of the Number of Administered Systemic Treatment Lines on Local Response to Radiation Therapy for Multiple Myeloma"],"prefix":"10.1016","volume":"10","author":[{"given":"Andrea Emanuele","family":"Guerini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5525-2945","authenticated-orcid":false,"given":"Eneida","family":"Mataj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Borghetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Triggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Pegurri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Nici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Riga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Belotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Lorenzo","family":"Bon\u00f9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Facheris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano Maria","family":"Magrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Spiazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Buglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2024.101696_bib0001","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.annonc.2020.11.014","article-title":"Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020","volume":"32","author":"Dimopoulos","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.adro.2024.101696_bib0002","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1016\/j.prro.2023.11.004","article-title":"Real-world utilization of radiation therapy in multiple myeloma: An analysis of the connect MM registry","volume":"14","author":"Ballas","year":"2024","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2024.101696_bib0003","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ijrobp.2018.05.009","article-title":"Radiation therapy for solitary plasmacytoma and multiple myeloma: Guidelines from the International Lymphoma Radiation Oncology Group","volume":"101","author":"Tsang","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101696_bib0004","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1016\/j.ijrobp.2023.06.068","article-title":"Phase II multi-institutional study of a low-dose (4 Gy) palliative response-adapted radiotherapy regimen for symptomatic bone metastases from multiple myeloma: Planned interim analysis of first 40 patients","volume":"117","author":"Ballas","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101696_bib0005","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.6004\/jnccn.2023.0061","article-title":"Multiple myeloma, version 2.2024, NCCN clinical practice guidelines in oncology","volume":"21","author":"Kumar","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.adro.2024.101696_bib0006","doi-asserted-by":"crossref","first-page":"3750","DOI":"10.1038\/s41467-022-31430-0","article-title":"The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma","volume":"13","author":"Vo","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.adro.2024.101696_bib0007","first-page":"131","article-title":"IMiD resistance in multiple myeloma: Current understanding of the underpinning biology and clinical impact","volume":"142","author":"Bird","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.adro.2024.101696_bib0008","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejca.2018.12.024","article-title":"Sequence-dependent cross-resistance of combined radiotherapy plus BRAFV600E inhibition in melanoma","volume":"109","author":"Shannan","year":"2019","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.adro.2024.101696_bib0009","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12943-023-01801-2","article-title":"Molecular mechanisms of tumor resistance to radiotherapy","volume":"22","author":"Wu","year":"2023","journal-title":"Mol Cancer"},{"key":"10.1016\/j.adro.2024.101696_bib0010","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/oxfordjournals.annonc.a058173","article-title":"Cross resistance between radiotherapy and chemotherapy in cancer treatment: What can be done about it?","volume":"3","author":"Mirimanoff","year":"1992","journal-title":"Ann Oncol"},{"key":"10.1016\/j.adro.2024.101696_bib0011","article-title":"Cross-resistance among sequential cancer therapeutics: An emerging issue","volume":"12","author":"Loria","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.adro.2024.101696_bib0012","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.18632\/oncotarget.2176","article-title":"Acquisition of radioresistance in docetaxel-resistant human lung adenocarcinoma cells is linked with dysregulation of miR-451\/c-Myc-survivin\/rad-51 signaling","volume":"5","author":"Wang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.adro.2024.101696_bib0013","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1042\/CBI20100061","article-title":"Effect of cobalt-60 (\u03b3 radiation) on multidrug-resistant multiple myeloma cell lines","volume":"35","author":"Mutlu","year":"2011","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.adro.2024.101696_bib0014","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3390\/cancers15051558","article-title":"Novel agents as main drivers for continued improvement in survival in multiple myeloma","volume":"15","author":"Puertas","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.adro.2024.101696_bib0015","article-title":"Biological effective radiation dose for multiple myeloma palliation","volume":"8","author":"Meredith","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2024.101696_bib0016","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.3324\/haematol.2019.235804","article-title":"New paradigm for radiation in multiple myeloma: Lower yet effective dose to avoid radiation toxicity","volume":"105","author":"Elhammali","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.adro.2024.101696_bib0017","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.clml.2021.09.015","article-title":"The safety and efficacy of radiation therapy with concurrent dexamethasone, cyclophosphamide, etoposide, and cisplatin-based systemic therapy for multiple myeloma","volume":"22","author":"Nehlsen","year":"2022","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.adro.2024.101696_bib0018","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jare.2021.06.006","article-title":"Neurophysiological mechanisms of cancer-induced bone pain","volume":"35","author":"Zheng","year":"2021","journal-title":"J Adv Res"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109424002598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109424002598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T07:39:41Z","timestamp":1744875581000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109424002598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2452109424002598"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2024.101696","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the Number of Administered Systemic Treatment Lines on Local Response to Radiation Therapy for Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2024.101696","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101696"}}